Skybiotech Healthcare Limited (BOM:512036)
India
· Delayed Price · Currency is INR 138.90
0.00 (0.00%)
At close: Apr 17, 2026
Skybiotech Healthcare Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Net Income | - | -23.69 | 15.35 | -0.07 | -0.38 | -0.48 | Upgrade
|
| Depreciation & Amortization | - | 5.42 | 0.01 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -1.28 | -18.72 | -0.22 | - | - | Upgrade
|
| Other Operating Activities | - | -5.59 | -12.4 | -3.45 | 6.49 | 12.97 | Upgrade
|
| Change in Accounts Receivable | - | 5.52 | -0 | - | 0.01 | 0 | Upgrade
|
| Change in Inventory | - | 0.98 | - | - | - | - | Upgrade
|
| Change in Accounts Payable | - | -0.17 | 3.99 | -0.01 | -0.01 | 0.03 | Upgrade
|
| Change in Other Net Operating Assets | - | 8.39 | -1.6 | 0.01 | -0.04 | 0.25 | Upgrade
|
| Operating Cash Flow | - | -10.43 | -13.37 | -3.73 | 6.1 | 12.8 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | -52.37% | - | Upgrade
|
| Capital Expenditures | - | -3.26 | - | - | - | - | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | - | 0 | Upgrade
|
| Investment in Securities | - | -93.56 | 34.97 | 3.46 | -6.45 | -12.92 | Upgrade
|
| Other Investing Activities | - | 0.52 | 1.3 | 0.32 | 0.29 | 0.18 | Upgrade
|
| Investing Cash Flow | - | -96.29 | 36.27 | 3.79 | -6.15 | -12.74 | Upgrade
|
| Long-Term Debt Issued | - | 6.98 | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | 6.98 | - | - | - | - | Upgrade
|
| Issuance of Common Stock | - | 5.51 | 61.25 | - | - | - | Upgrade
|
| Other Financing Activities | - | -0.12 | - | - | - | - | Upgrade
|
| Financing Cash Flow | - | 12.37 | 61.25 | - | - | - | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | -0 | - | - | - | - | Upgrade
|
| Net Cash Flow | - | -94.35 | 84.15 | 0.06 | -0.06 | 0.06 | Upgrade
|
| Free Cash Flow | - | -13.68 | -13.37 | -3.73 | 6.1 | 12.8 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | -52.37% | - | Upgrade
|
| Free Cash Flow Margin | - | -18.40% | -66.76% | -688.68% | 2683.86% | 6550.84% | Upgrade
|
| Free Cash Flow Per Share | - | -7.14 | -6.98 | -3.59 | 5.86 | 12.31 | Upgrade
|
| Cash Interest Paid | - | 0.12 | - | - | - | - | Upgrade
|
| Cash Income Tax Paid | - | - | 3.39 | - | - | - | Upgrade
|
| Levered Free Cash Flow | - | -13.66 | 14.12 | -0.03 | -0.25 | -0 | Upgrade
|
| Unlevered Free Cash Flow | - | -13.59 | 14.12 | -0.03 | -0.25 | -0 | Upgrade
|
| Change in Working Capital | - | 14.72 | 2.39 | -0 | -0.04 | 0.28 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.